When:
Monday, August 12, 2024 - 12:00am
Novo Nordisk is seeking novel cell delivery solutions to improve cell therapy treatments in humans. Specifically, the team is interested in device, biomaterial and formulation approaches to improve efficacy in Type 1 Diabetes, Chronic Heart failure and Parkinson’s Disease.